KRISTIN LEUGERS: Open Payments
NPI 1306487830 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,325 in 56 payments from 11 companies in 2025. Trend: 2023 $1,465 · 2024 $1,733 · 2025 $1,325
Food & beverage: $1,325
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 13 | $581 |
| AstraZeneca Pharmaceuticals LP | 11 | $175 |
| GlaxoSmithKline, LLC. | 14 | $154 |
| Merck Sharp & Dohme LLC | 5 | $123 |
| Regeneron Healthcare Solutions, Inc. | 5 | $122 |
| Viatris Specialty LLC | 2 | $55 |
| Amgen Inc. | 2 | $39 |
| Verona Pharma, Inc. | 1 | $26 |
| GENZYME CORPORATION | 1 | $18 |
| Insmed, Inc. | 1 | $17 |
Products named: Tyvaso, DUPIXENT, WINREVAIR, FASENRA, NUCALA, YUPELRI, TRELEGY ELLIPTA, TEZSPIRE.
Industry payments across OH — which companies pay providers there.
